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Selenate reductase (SER) from Thauera 
selenatis is a periplasmic enzyme that has been 
classified as a type II molybdoenzyme.  The 
enzyme comprises three subunits SerABC, 
where SerC is an unusual b-heme cytochrome.  
In the present work the spectropotentiometric 
characterization of the SerC component and 
the identification of redox partners to SER are 
reported.  The mid-point redox potential of the 
b-heme was determined by optical titration (Em 
+234±10 mV).  A profile of periplasmic c-type 
cytochromes expressed in T. selenatis under 
selenate respiring conditions was undertaken.  
Two c-type cytochromes were purified, (~24 
kDa and ~6 kDa), and the 24 kDa protein (cytc-
Ts4) was shown to donate electrons to SerABC 
in vitro.  Protein sequence of cytc-Ts4 was 
obtained by N-terminal sequencing and LC-
MS/MS analysis, and based upon sequence 
similarities, was assigned as a member of 
cytochrome c4 family.  Redox potentiometry, 
combined with UV-visible spectroscopy, 
showed that cytc-Ts4 is a diheme cytochrome 
with a redox potential of +282±10 mV and both 
hemes are predicted to have His-Met ligation.  
To identify the membrane-bound electron 
donors to cytc-Ts4, growth of T. selenatis in the 
presence of respiratory inhibitors was 
monitored.  The specific quinol-cytochrome c 
oxidoreductase (QCR) inhibitors myxothiazol 
and antimycin A partially inhibited selenate 
respiration, demonstrating that some electron 
flux is via the QCR.  Complete inhibition of 
selenate respiration was achieved with the 
more general inhibitor 2-n- heptyl- 4-
hydroxyquinoline N-oxide (HQNO).  Electron 
transfer via a QCR and a diheme cytochrome 
c4 is a novel route for a member of the DMSO 
reductase family of molybdoenzymes. 
 
Within the DMSOR1 family of type II 
molybdoenzymes (1) there is a distinct clade of 
enzymes that are translocated to the periplasm 
using the twin arginine translocation (TAT) 
pathway (2,3) and possess a monomeric b-type 
heme-containing γ-subunit (1).  The enzymes 
within this clade function as either 
dehydrogenases (e.g. ethylbenzene dehydrogenase 
from Aromatoleum aromaticum (4), 
dimethylsulphide dehydrogenase from 
Rhodovulum sulfidophilum (1,5) or reductases 
(e.g. selenate reductase from Thauera selenatis 
(6,7), chlorate reductase from Ideonella 
dechloratans (8,9), and catalyze either hydride or 
oxygen transfer as generalized by equation [1].   
 
X + H2O ' XO + 2H+ + 2e-  [1] 
 
These soluble enzymes consist of three 
subunits and in addition to the b-heme 
cytochrome (γ-subunit), they comprise an iron-
sulfur protein (β-subunit) co-ordinating 1x[3Fe-
4S] cluster and 3x[4Fe-4S] clusters, and a 
catalytic component (α-subunit) that co-ordinates 
a [4Fe-4S] cluster and the active site molybdenum 
                                                 
1 MGD, molybdenum guanine dinucleotide; SER, 
periplasmic selenate reductase; NAR, membrane-
bound nitrate reductase; EBDH, ethylbenzene 
dehydrogenase; DMSDH, dimethyl sulfide 
dehydrogenase; DMSOR, dimethylsulfoxide reductase; 
FDH, formate dehydrogenase; FeS/FS0, iron-sulfur 
clusters; HQNO, 2-n-heptyl-4-hydroxyquinoline N-
oxide; TMAOR, trimethylamine N-oxide reductase; 
TAT, twin-arginine translocation; QCR, quinol-
cytochrome c oxidoreductase; QDH, quinol 
dehydrogenase; DH, primary dehydrogenase; PMF, 
proton-motive force; OFN, oxygen free nitrogen.  
             
 
 2
guanine dinucleotide (MGD) cofactor (10,11) 
(Figure 1).  The reductases play a pivotal 
function, coupling the reduction of substrates to 
the generation of the proton motive force (PMF).  
Identifying the route by which electrons are 
transferred to these reductases is vital to 
understanding their bioenergetics (12).  How 
periplasmic substrate reduction can generate a 
PMF, that is sufficient to support growth, is of 
considerable interest.  The use of selenate and 
selenite as bacterial respiratory substrates has 
been well documented (13).  By far the most well 
studied selenate-respiring bacterium has been T. 
selenatis; however, the characterisation of the 
selenate respiratory system has not yet addressed 
the mechanism by which electrons are transferred 
from the cytoplasmic membrane to the 
periplasmic selenate reductase (SerABC).  As 
SerABC appears to be soluble and not associated 
with the inner or outer membrane (6), it is likely 
that another protein acts as a shuttle to take 
electrons from the membrane and deliver them to 
the b-heme of SerC.  Reduced SerC then donates 
electrons, via the iron-sulfur clusters of SerAB 
(11), specifically to the molybdopterin co-factor 
for reduction of selenate (SeO42-) to selenite 
(SeO32-) (6,14,11).  
The b-heme of SerC is presumed to be the site 
of electron entry to the SER enzyme complex, but 
also remains poorly studied.  The recently solved 
crystal structure of ethylbenzene dehydrogenase 
(EBDH) reveals that its γ-subunit also binds an 
unusual b-type heme, which is coordinated by 
methionine and lysine ligands (15).  This co-
ordination favours the uncharged ferrous heme 
over the charged ferric form and as such 
modulates a relatively high redox potential of 
+254 mV.  Similarly, optical potentiometeric 
redox titrations of the heme b in the γ-subunit of 
dimethylsulphide dehydrogenase (DMSDH) 
revealed a high redox potential of Em = +324mV 
(10).  By contrast, the cytoplasmic-facing 
respiratory nitrate reductase NAR from 
Escherichia coli (another member of the type II 
molybdoenzymes) possesses a membrane bound 
γ-subunit (NarI) that co-ordinates two bis-His 
ligated b-hemes that have much lower redox 
potentials at +20 and +120 mV (16).  In the case 
of NAR, the low redox potentials of the heme 
favours electron flow away from NarI, towards 
the MGD cofactor in NarG, and ultimately 
resulting in the reduction of nitrate to nitrite.  
Critically, the dehydrogenases (EBDH and 
DMSDH) function in the reverse direction (figure 
1); it has been argued that due to the unusually 
high potential b-heme in γ-subunits of both EBDH 
and DMSDH, that the γ-subunit is the site of 
electron egress from these enzymes to their redox 
partners (10,15).  Consequently, the high potential 
b-heme might function to draw electrons away 
from, rather than towards, the MGD cofactor 
during catalysis as displayed in the nitrate 
reductase enzymes.  Analysis of the amino acid 
sequence alignment of EBDH and DMSDH with 
selenate reductase (SER) shows that the co-
ordinating methionine (M138) and lysine (K228) 
residues are also conserved in SerC.  This then 
raises interesting questions as to what is the redox 
potential for the b-heme in the reductase members 
of this distinct type II clade and what are the 
likely redox partners?   
Among the related type II molybdoenzymes, 
there are a number of different routes of electron 
transfer to terminal reductases, although the 
majority catalyze reactions with a lower redox 
potential than the selenate/selenite couple (+475 
mV). For example; the DMSO/DMS couple is 
+160 mV and TMAO/TMA couple is +130 mV 
(17).  Within the DMSOR group, a number of 
pathways for electron transport have been 
established, and a variety of membrane-bound 
proteins have been implicated.  These membrane-
bound cytochromes are responsible for extracting 
electrons from the quinol pool so that they can be 
transferred to the associated downstream terminal 
reductases.  The existing literature provides 
several routes by which electrons are transferred. 
For example, the membrane bound nitrate 
reductase NarGH (16,18) receives its electrons 
from its dedicated NarI membrane integral 
subunit, which contains two b-hemes; the DMSO 
reductase from E. coli (DmsABC) has a similar 
organisation of subunits (17), but faces the 
periplasm. The E. coli TMAO reductase TorA 
(Rhodobacter sp.), DMSO reductase DorA (17), 
and the periplasmic nitrate reductase NapAB (19) 
accept electrons from dedicated tetra or penta-
heme quinol dehydrogenases in the membrane 
(TorC/DorC/NapC).  In the case of Nap, there is 
also an alternative pathway; the nap gene cluster 
in E. coli for example, also contains napG and 
napH, which encode iron-sulfur proteins 
responsible for electron transfer from ubiquinol to 
NapC (20).  
It may be the case that selenate respiration in 
T. selenatis does not occur via any of these known 
pathways; McEwan et al. (21) postulated that the 
selenate reductase of T. selenatis could receive 
electrons from quinol-cytochrome c 
oxidoreductase (QCR) via a high-potential c-type 
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cytochrome, due to the high potential of the 
selenate/selenite couple.  This has not been seen 
for any of the other type II molybdoenzymes so 
showing electron donation from QCR, via a 
soluble cytochrome c to SerABC would represent 
a novel electron transport chain within this group.  
The aim of the present work was to resolve the 
electron transfer pathways during selenate 
respiration in T. selenatis. 
         
 
EXPERIMENTAL PROCEDURES 
Growth of T. selenatis, production of 
periplasmic fractions and purification of SER. - T. 
selenatis was grown anaerobically at 30°C in 
mineral salts medium (6) containing yeast extract 
(0.1%), with either selenate or nitrite (10 mM) as 
terminal electron acceptors and acetate (10 mM) 
as the electron donor in 10 L batch cultures.  
Cultures were harvested during late log phase 
(after 16-18 hours growth) at A600 0.6-0.7 and 
spheroplasts were prepared as described 
previously (6).  The spheroplasts were removed 
by centrifugation (25,000 x g, 20 minutes) and the 
supernatant, containing the periplasm, was 
retained.  Periplasms were analysed by SDS-
PAGE and c-type cytochromes were visualised 
using the heme stain method.  SER was purified 
as detailed by Schröder et al. (6) with the 
modifications noted by Dridge et al. (11).  
Purified enzyme was stored at -80°C.  Purity was 
determined by SDS-PAGE and positive 
identification of the presence of the SerC 
component was achieved by N-terminal sequence 
analysis as described previously (22).  
  
Purification of c-type cytochromes - Soluble 
protein from a 10 L culture, was loaded onto a Q-
Sepharose Fast-Flow anion exchange column (70 
ml bed volume) (GE Healthcare) pre-equilibrated 
with 3 column volumes of 30 mM Tris, pH 8.5. 
The column was washed with a further column 
volume of buffer to remove unbound proteins. A 
24 kDa c-type cytochrome was eluted using a 300 
ml gradient of 0-300 mM NaCl in 30 mM Tris, 
pH 8.5. Protein concentration was monitored 
using absorbance at 280 nm and presence of 
cytochromes was monitored using absorbance at 
410 nm. The fractions containing the 24kDa c-
type cytochrome as determined by SDS-PAGE 
were pooled and concentrated using a 15 ml 10 
kDa MWCO centrifugal concentrator at 4000 x g. 
The concentrated protein was loaded onto a 
Superdex 200 16/60 gel filtration column (GE 
Healthcare) equilibrated with 2 column volumes 
of 30 mM Tris, pH 8.5 and eluted in the same 
buffer. The fractions containing the 24kDa c-type 
cytochrome were pooled and loaded onto a 1 ml 
MonoQ anion exchange column (GE Healthcare) 
equilibrated with 30 mM Tris, pH 8.5 and eluted 
with a gradient of 0-1 M NaCl in 30 mM Tris, pH 
8.5. As a final purification step, the fractions 
containing the 24 kDa c-type cytochrome were 
pooled and transferred to dialysis tubing (6 kDa 
MWCO) (Fisher), the protein was then dialysed 
overnight at 4°C, with gentle stirring, into 30 mM 
Tris, pH 8.5, containing 1 M ammonium sulfate. 
The dialysed protein was bound to a 25 ml Fast-
Flow Phenyl Sepharose column (GE Healthcare) 
pre-equilibrated with 1 M ammonium sulfate in 
30 mM Tris, pH 8.5, and subsequently eluted with 
a decreasing gradient of 1 to 0 M ammonium 
sulfate.  The cytochrome was judged pure by 
SDS-PAGE, concentrated as before and stored at 
4°C for short term use, or -80°C for longer term 
storage. All chromatography procedures were 
carried out using an AKTAPrime (GE Healthcare) 
purification system, except for the MonoQ 
column which was run on an AKTABasic (GE 
Healthcare).  The soluble fraction from a 2 L 
culture was also prepared as described above. 
This soluble fraction was concentrated using a 15 
ml 5 kDa MWCO centrifugal concentrator 
(Millipore) to a final volume of 5 ml, and then 
loaded onto a Superdex 200 16/60 gel filtration 
column pre-equilibrated with 20 mM Tris, pH 8.0. 
Proteins were eluted in the same buffer. Fractions 
were monitored for presence of protein using the 
absorbance at 280 nm for presence of cytochrome 
using the absorbance at 410 nm. Fractions 
containing the 6 kDa cytochrome were identified 
by SDS-PAGE, pooled, and concentrated in a 5 
ml 5 kDa MWCO concentrator. 
 
Electronic absorption spectroscopy - UV-
visible spectra of protein samples were recorded 
on a Varian Cary 4E UV/Vis spectrophotometer 
between 350-650 nm. Reduced samples were 
achieved by adding excess sodium dithionite and 
oxidized samples by the addition of potassium 
ferricyanide.  
 
Electron transfer assay - To determine 
whether purified cytochromes were able to donate 
electrons to SerABC in vitro, a solution of 
approximately 5 μM cytochrome in 50 mM 
phosphate buffer (pH 7.5) was degassed in a 
sealed cuvette.  A weak solution (10 mM) of 
sodium dithionite was also degassed and then 
titrated into the cuvette using a 10 μl Hamilton 
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syringe, until the cytochrome was fully reduced, 
as determined by wavelength scanning UV-visible 
spectroscopy (350-700 nm). SerABC and selenate 
were added to final concentrations of 1 μM and 20 
mM respectively, and re-oxidation of the 
cytochrome monitored by recording the spectra. 
Cytochromes were similarly tested for selenate 
and selenite reductase activity by incubation with 
the relevant substrate but no SerABC. 
 
Optical redox titrations - Optical spectra of 
the samples were measured on a Hitachi U-3310 
spectrophotometer between 350-700 nm. Protein 
samples were added to a stirred cuvette constantly 
sparged with OFN to minimise oxidation from air. 
Redox mediators (2,3,5,6 tetramethyl-p-
phenylendiamine, 1,2 napthoquinone, 
phenozinemethosulfate, phenylethosulfate, 
juglone, duroquinone, menadion) were added to a 
final concentration of 6 μM each, and the 
potential measured using an electrode (23). The 
electrode was initially calibrated with reference to 
a saturated solution of quinhydrone (295 mV vs. 
SHE). A degassed solution of 5 mM sodium 
dithionite was prepared and added in 1 μl steps, 
recording the potential, and the spectra at each 
step. Once the sample was fully reduced, 3 mM 
potassium ferricyanide was titrated in similarly to 
re-oxidise the sample. The fraction of protein 
reduced at each potential was calculated and fitted 
to a Nernstian equation using the curve fitting 
program TableCurve 2D (Systat Software Inc.). 
 
Sequence analysis of the 24 kDa cytochrome - 
N-terminal sequencing of the 24 kDa cytochrome 
was undertaken at the Pinnacle Proteomic facility, 
Newcastle University. Native 24 kDa cytochrome 
c was also digested in solution using Trypsin Gold 
(Promega) according to the manufacturers’ 
instructions. Briefly, Trypsin Gold in 50 mM 
acetic acid was mixed with the cytochrome (in 30 
mM Tris, pH 8.5) in a ratio of 1:20 w/w 
protease:protein. The mixture was incubated at 
37°C for 1 hour, and analysed by SDS-PAGE.  
Protein bands of interest were excised for 
analysis, which was carried out using LC-MS/MS 
at the University of York Proteomics department.   
 
Sequencing the T. selenatis genome using 
Illumina sequencing - Genomic DNA was 
extracted and fragmented to using the Bioruptor 
apparatus and fragments of 200 bp were selected 
using an agarose gel purification protocol.  These 
fragments were then prepared using the standard 
Illumina paired-end library preparation protocols.  
The resulting DNA was purified using an 
acrylamide gel and these were sequenced using an 
Illumina GA2 sequencer using a single lane 
loaded at 6pM.  Illumina version 2 reagents were 
used together with Illumina SCS 2.3 and Illumina 
Pipeline 1.3 software to base call.  This produced 
15,422,089 36bp paired-end sequences.  These 
were subsequently trimmed to remove or shorten 
reads which contained adaptor sequence.  Read 2 
contained unusually high error rates toward the 3’ 
end of the reads.  Where appropriate these were 
shortened prior to any de-novo assembly to 
remove bases with quality scores less than 20. 
MAQ (http://maq.sourceforge.net/) was used 
to align these sequences to the reference genome 
Thauera MZ1T (Genbank accession CP001281 
and CP001282). This was achieved with an 
average depth of 32.9 across non-gap regions.  
Unmapped reads were then collated and 
assembled de-novo using Velvet (version 0.7.47) 
in single-end mode using a hash length of 21 (24).  
These unmapped reads generated an assembly 
with 14,870 contigs and an N50 length of 1223 
bp.  These contigs represent genomic regions 
present in T. selenatis but which are absent in 
Thauera MZ1T.  Additionally a completely de-
novo assembly was produced using Velvet in 
paired end mode using a parameter sweep of hash 
length and coverage cut-off.  A hash length of 25 
and a coverage cut-off of 5 was found to produce 
the highest N50. This resulted in an assembly of 
769 contigs with an N50 value of 135, 919 bp 
(made up of 17 contigs) and a total length of 
9.48Mb.  
 
Micro-culture growth and respiratory 
inhibition studies - In order to monitor the effects 
of changing culture conditions and inhibitors on 
the growth of T. selenatis, a method utilising 
micro-culture was developed.  A 500 ml bottle of 
mineral salts medium was prepared without the 
addition of selenate or other electron acceptor. 
The bottle was sealed with rubber septa and 
sparged with OFN for at least 1 hour.  Each well 
of a 96-well microtitre plate had 250 μl of the 
degassed medium added to it, and electron 
acceptor added in varying concentrations from 
degassed stock solutions.  Inhibitors, myxothiazol, 
antimycin A and HQNO, at a range of 
concentrations, were added to wells as required. 
Wells were inoculated with 1 μl washed cells 
from an exponential phase T. selenatis culture (1 
ml of cells at OD600nm 0.6-0.7 were harvested by 
centrifugation at 12,000 x g, 2 minutes, and 
resuspended in 1 ml of the degassed media).  
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Inoculated plates were incubated in a FLUOstar 
Optima microplate reader (BMG Labtech) 
attached to a nitrogen cylinder to keep the plate in 
an anaerobic atmosphere. The plate was 
maintained at a constant temperature of 30°C, and 
OD600nm values were measured in each well every 
15 minutes using the kinetics measuring program, 
with 5 seconds shaking before each reading.  Each 
plate had 6 wells without the addition of bacteria 
to ensure no contaminants were growing, and to 
act as a baseline, and 6 wells with non-inhibiting 
growing conditions for T. selenatis to check the 
culture was growing typically.  The maximum 
gradient at exponential growth was determined by 
fitting the growth curves to the Gompertz 
equation (25).  All growth conditions were 
replicated at a range of substrate concentrations 
and using non-linear regression, the maximum 
growth rate (μmax) of the culture was calculated 
using the Monod equation [2] (26): 
 
μ = μmax ([S]/Ks + [S])  [2] 
 
RESULTS 
 
Cytochrome c profile during selenate 
respiration - The c-type cytochromes expressed 
during selenate respiration in T. selenatis were 
profiled by heme staining SDS-PAGE resolved 
periplasmic proteins. Several soluble cytochromes 
were identified (referred to as cytc-Ts1-Ts7; in 
size order) (Figure 2A) and by comparing the 
expression profile to nitrate grown cells, a number 
of cytochromes were found to be more highly 
expressed during selenate respiration.  Cytc-Ts1 is 
present under both growth conditions but to a 
lesser extent when grown on selenate.  Cytc-Ts2 
is poorly resolved but present as a band at 
approximately 40 kDa in selenate grown cells. 
Cytc-Ts3 (~33 kDa) is again expressed under both 
growth conditions.   Cytochromes identified as 
cytc-Ts5 and cytc-Ts6 were resolved only in 
selenate grown cells.  Cytc-Ts4 (24 kDa) and 
cytc-Ts7 (6 kDa) were both significantly up-
regulated under selenate growth conditions and 
selected for further investigation.  Cytc-Ts4 and 
cytc-Ts7 were purified (Figure 2A) and tested as 
potential electron donors to SerABC. 
 
Characterisation of 6 kDa cytochrome (cytc-
Ts7) - The reduced UV-visible spectrum of the 
purified 6 kDa cytochrome (cytc-Ts7) was typical 
of a low-spin c-type cytochrome, with absorbance 
maxima at 415, 522 and 551 nm (Figure 2C). The 
oxidized spectrum shows a shift in the Soret band 
to 409 nm and a broad feature around 525 nm. In 
order to test the ability of this cytochrome to 
donate electrons to SerABC, it was reduced by 
titration with a weak solution of sodium 
dithionite, and mixed with purified selenate 
reductase and selenate in an anaerobic assay.  No 
re-oxidation of the heme was observed suggesting 
that the 6 kDa cytochrome is not able to act as 
electron donor to SerABC in vitro (data not 
shown).  
 
Characterisation of the 24 kDa cytochrome 
(cytc-Ts4) - UV-visible spectroscopy of the 24 
kDa cytochrome (cytc-Ts4) is again typical of a 
low-spin heme c (Figure 2B). It is purified in a 
partially reduced state, but does not readily 
become oxidized, even after lengthy exposure to 
air.  Protein reduced with dithionite shows a Soret 
band at 414 nm, an α-band at 550 nm and a β-
band at 519 nm. The α-band shows asymmetry, 
with a shoulder at 545 nm suggesting a composite 
band, possibly due to the presence of more than 
one heme in the protein. Oxidized with 
ferricyanide, the cytochrome has a Soret band at 
409 nm and a broad feature at 528 nm. As for 
cytc-Ts7, cytc-Ts4 was tested for its ability to 
donate electrons to SerABC in an anaerobic assay.  
In this case, after incubation with enzyme and 
substrate, the visible absorbance spectrum is 
shifted (Figure 3).  The Soret band shifts from 414 
nm to 410, and decreases in intensity, and the α/β 
peaks broaden and decrease in intensity, 
indicative of re-oxidation of the heme.  Cytc-Ts4 
incubated with SerABC, selenate or selenite alone 
did not exhibit any shifts in absorbance (data not 
shown), suggesting that this cytochrome is 
capable of donating electrons to SerABC for the 
reduction of selenate to selenite in vitro, and 
therefore could be an in vivo electron donor to 
SerABC.  The rate of cytc-Ts4 heme oxidation 
was determined to be some 50 times slower than 
the observed rate of SER turnover determined 
using methyl viologen as the electron donor (6).  
Similarly, Craske and Ferguson (27) have shown 
that NAR from P. denirificans has a 50-fold 
higher Vmax with methyl viologen than with 
duroquinol.   
  
Determination of the redox potential of cytc-
Ts4 - The redox potential of the heme of cytc-Ts4 
was measured spectrophotometrically by 
monitoring the absorbance of the α-band at 551 
nm (adjusted by reference to an isosbestic point at 
560 nm) during reduction or oxidation of the 
heme (Figure 4A). The fraction of protein reduced 
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at each measured potential was calculated, then 
plotted as a function of redox potential vs. the 
standard hydrogen electrode (SHE) (Figure 4B). 
Nernst curves for n=1 and n=2 (where n is number 
of electrons transferred) were fitted and are also 
shown in figure 4B.  Interestingly, the data fits 
more closely to an n=2 curve, suggesting the 
cytochrome has 2 hemes.  A mid-point potential 
of +282 ±10 mV for the cytochrome was 
calculated, but we were unable to resolve 2 
separate potentials.  
 
Sequence determination and analysis - 
MALDI-TOF analysis of cytc-Ts4 gave a 
molecular weight of 23,558 Da, not including 
heme groups. N-terminal sequencing (Pinnacle 
Proteomic facility, Newcastle University) and LC-
MS/MS of tryptic digest fragments (University of 
York Proteomics dept.) resulted in 60 aa of 
sequence data which was used to identify the gene 
for this cytochrome from the draft genome 
assembly of T. selenatis.  Peptides were searched 
against a custom Blast (28) database containing 
all contigs generated from the sequence data 
which could not be mapped to Thauera MZ1T and 
separately to another database containing the 
complete set of contigs generated from all 
Illumina T.selenatis data.  Due to the short lengths 
of the peptides only 2 significant hits were 
obtained and these contigs were used as targets 
for further investigation.  ORF prediction was 
carried out using the CLC-Bio software package 
and candidate regions searched via Blast against 
the non-redundant database of protein sequences.  
The sequence of cytc-Ts4 (Genbank accession 
GU570563) was used to search the database and 
an alignment of similar cytochromes is shown in 
supplemental figure S1.  Alignment of the 
predicted amino acid sequences shows the 
presence of two conserved CXXCH motifs 
consistent with the binding of two covalently 
attached hemes.  The presence of two further 
conserved methionine residues suggests that both 
hemes are His-Met co-ordinated.   
 
Determination of the redox potential of the b-
heme in SerC - Purified SER was used to 
determine the midpoint potential of the b-heme in 
SerC, the point of electron entry to the reductase 
from the cytc redox partner.  The redox potential 
of the heme was determined by optical redox 
titration by monitoring the absorbance of the 
heme at 558 nm (adjusted with reference to an 
isosbestic point at 575 nm) during sequential 
oxidation and reduction of the heme (Figure 5A).  
The slight drift observed in the spectrum is due to 
the contribution of the [Fe-S] clusters in SerAB.  
The absorbance was monitored at the α-band 
wavelength rather than that of the Soret band, as 
the redox mediators used do not absorb in the α-
band region, but might interfere at Soret band 
wavelengths.  The fraction of protein reduced at 
each measured potential was calculated and then 
plotted as a function of redox potential (Figure 
5B).  The Nernst curve corresponding to n=1 
electrons was fitted to the data giving a midpoint 
potential of +234±10 mV.   
 
Quinol-cytochrome c oxidoreductase is an 
electron donor to selenate reductase in T. 
selenatis - Soluble cytochromes acting as electron 
carriers need to accept electrons from an upstream 
donor. Commonly, this comes in the form of a 
quinol-cytochrome c oxidoreductase (QCR), 
which can contribute to the PMF via the Q-cycle.  
In order to investigate whether the QCR is 
involved in selenate respiration and could 
therefore be responsible for electron transfer to 
the di-heme cytochrome (cytc-Ts4), classical 
inhibitors of respiratory chains were used during 
selenate and nitrite respiration.  The inhibitors 
myxothiazol and antimycin A specifically inhibit 
the QCR, but at different sites (29).  Myxothiazol 
binds to the Qo site on the b heme subunit of 
QCR.  The Qo site is where quinol is oxidised to 
quinone, and the binding of myxothiazol stops 
electrons being transferred from the Q-pool to 
downstream electron acceptors.  By contrast, 
antimycin A binds to the Qi site of QCR 
preventing the reduction of quinone to quinol.  
HQNO (2-n-heptyl-4-hydroxyquinoline N-oxide) 
is a less specific quinone analogue which inhibits 
not only the QCR (30), but also the membrane 
bound nitrate reductase subunit NarI (31) and 
multi-heme quinol dehydrogenases such as NrfH 
from Wolinella succinogenes nitrite reductase 
(32). 
In order to culture T. selenatis under more 
reproducible conditions, and allow multiple 
replicates of growth curves, a method of culturing 
T. selenatis in a 96 well microplate was devised.  
All growth conditions were replicated in 10 wells, 
allowing averaging of the optical densities over 
each time point. Before averaging, the optical 
density of a control set of wells of medium with 
no bacterial culture was subtracted from the 
growth curves.  In order to test whether 
concentrations of inhibitor were high enough to 
inhibit T. selenatis, the microplate method was 
used to investigate the effect of myxothiazol on 
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nitrite respiration, to see if complete inhibition 
could be achieved.  Thauera sp. is known to 
express a cd1 nitrite reductase (33, 34) which 
commonly receives its electrons from the QCR 
via soluble intermediates (35). A range of nitrite 
concentrations were used, with myxothiazol at 10 
μM.  Ten wells contained 5 mM nitrite, but no 
inhibitor.  Myxothiazol was seen to inhibit nitrite 
respiration very effectively and no growth was 
observed (Figure 6A).  This confirms the 
effectiveness of myxothiazol as an inhibitor of the 
QCR in T. selenatis. 
T. selenatis was cultured under selenate 
respiratory conditions, with varying 
concentrations of selenate and 10 μM 
myxothiazol.  Ten wells contained 10 mM 
selenate but lacked myxothiazol, as a positive 
control.  The resulting growth curves (Figure 6A) 
indicate that selenate respiration is partially 
inhibited by myxothiazol, suggesting that the 
QCR is involved in this process.  The experiments 
were repeated in the presence of the inhibitor 
antimycin A (at both 10 μM and 20 μM) and the 
results (Figure 6B) are consistent with the 
observations made using myxothiazol, strongly 
indicating the involvement of QCR in electron 
transport.  Again, even at 20 μM [antimycin], 
some growth is detected (final OD600nm ~0.3 
units).  Analysis of the specific growth rates (μmax) 
at increasing [selenate] shows that Ks is unaffected 
(~2.5 mM); however, in the presence of 
myxothiazol, a three-fold decrease in μmax is 
recorded (No inhibitor = 0.32 ± 0.03 h-1; plus 
myxothiazol = 0.10 ± 0.02 h-1) (Figure 6C).   
Therefore, it can be seen, from the growth curve 
analysis, that both myxothiazol and antimycin A 
retard the growth rate of T. selenatis during 
selenate respiration, but does not inhibit it 
completely. 
 
Inhibition of selenate respiration by HQNO - 
As myxothiazol has been shown to fully inhibit 
the QCR in nitrite reduction, but is only partially 
effective at inhibiting selenate respiration, HQNO 
was used as an inhibitor which affects a wider 
range of proteins with quinol dehydrogenase 
activity.  HQNO was shown to inhibit growth 
completely with no significant change in culture 
OD for ~14 hours post inoculation.  Cultures 
maintained for 14-18 hours showed a slight 
increase in culture OD presumably due to the 
break-down or evaporation of HQNO from the 
growth medium (Figure 6A).  By combining both 
inhibitors, HQNO and myxothiazol, there was no 
significant difference between the growth curves 
obtained with HQNO alone.  The results (Figure 
6A) show that partial inhibition of selenate 
respiration is obtained by myxothiazol (and 
antimycin A) whereas complete inhibition of 
selenate respiration is obtained by HQNO.  The 
combined data suggest that there is more than one 
route by which electrons can be transferred to 
selenate reductase; via the QCR which is inhibited 
by myxothiazol and antimycin A, and via another 
type of quinol dehydrogenase which is inhibited 
by HQNO. 
 
DISCUSSION 
The bioenergetics of selenate respiration in T. 
selenatis has remained unresolved since the 
isolation of T. selenatis by Macy and co-workers 
in 1993 (36).  The respiration of selenate results in 
the sequential reduction of selenate to selenite to 
elemental selenium, yet it is only selenate that can 
function as a respiratory substrate.  Selenate 
reductase (SER) is a soluble molybdoenzyme 
comprised of three subunits and is expressed from 
an operon of four genes (7), three for the 
structural components and the forth (SerD) a 
private chaperone for the functional assembly of 
SerA.  No obvious membrane bound component 
has been identified.  Whilst others have 
speculated as to how SER receives electrons from 
the Q-pool and how this is coupled to the 
generation of PMF (21), biochemical evidence for 
the electron transfer pathway in T. selenatis has 
remained wanting.  In the present study we have 
demonstrated that SER can receive electrons from 
a di-heme cytochrome of the cytc4 family and is 
driven by electron transfer via a branched 
pathway that includes electron transfer from QCR 
or QDH.  The demonstration of an electron 
transfer pathway to a periplasmic molybdoezyme 
that utilises a high potential di-heme cytochrome c 
carrier and electron flux through QCR is the first 
of its kind and unprecedented in other molybdo-
oxidoreductase systems. 
A number of periplasmic c-type cytochromes 
were up-regulated when T. selenatis was grown 
on selenate as the sole electron acceptor.  During 
this study, two of these cytochromes have been 
purified and tested as potential redox partners to 
SER.  A 24k Da cytochrome, termed cytc-Ts4 
was shown to donate electrons to SER and was 
characterised further.  N-terminal sequence and 
LC-MS/MS analysis identified peptides as those 
resulting from members of the cytochrome c4 
family.  Attempts to PCR and sequence the cytc-
Ts4 gene using degenerate primers derived from 
other c4 homologues failed.  Consequently, a 
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holistic approach was adopted and the entire 
genome of T. selenatis was sequenced using an 
Illumina sequencer.  The complete cytc-Ts4 gene 
sequence was subsequently identified.  A database 
search with the translated sequence of this gene 
produced a large number of similar proteins, most 
of which are classified as cytochromes c4, a group 
of di-heme cytochromes c characterised by high 
redox potentials, a low intensity asymmetrical α 
band around 550 nm and a low α/β peak ratio 
(37,38). A number of members of this group have 
been characterised, including members from 
Acidithiobacillus ferrooxidans (39,40), 
Pseudomonas stutzeri (41), Thiocapsa 
roseopersicina (42) and Azotobacter vinelandii 
(43).  Cytochromes c4 have been proposed to be 
electron donors to oxidases due to the presence of 
a cytochrome c4 in the aerobe A. vinelandii (43) 
but the discovery of a cytochrome c4 in 
T. roseopersicina, a facultative anaerobic 
photosynthetic bacterium, suggests that their roles 
are much more varied (42,44).  Recently, a cytc4 
has also been found to function as a physiological 
electron carrier in the photosynthetic electron 
transport chain in Rubrivivax gelatinosus (45). 
Structural data is available for two 
cytochromes c4, from P. stutzeri (46) and A. 
ferrooxidans (47). The two hemes in each case 
both have His-Met axial ligation, and the 
methionine residues identified as ligands are 
conserved throughout the cytochrome c4 group, 
and in the cytc-Ts4.  The sequence similarity and 
high redox potential of the 24 kDa cytochrome 
suggest that we can assign cytc-Ts4 to the 
cytochrome c4 group.  The involvement of a c4 
cytochrome in anaerobic selenate respiration 
defines a new role for this class of cytochromes.     
Of the other cytochromes up-regulated during 
growth of T. selenatis on selenate, a 6kDa 
cytochrome was also purified (cytc-Ts7).  No 
evidence was obtained to suggest that cytc-Ts7 
could transfer electrons to SER.  Furthermore, no 
direct reduction of selenate or selenite was 
observed.  The function of cytc-Ts7 remains to be 
established.  Chlorate reductase from I.  
dechloratans is also a member of the TAT-
translocated type II molybdo-enzymes and is 
closely related to SER.  It has been shown 
recently that a 6 kDa cytochrome from I. 
dechloratans was readily oxidized in the presence 
of chlorate and cell homogenate containing 
chlorate reductase (Clr) (48), suggesting that a 6 
kDa cytochrome could be the redox partner for 
Clr.  The authors suggest that the 6 kDa 
cytochrome might accept electrons from QCR, but 
no biochemical evidence for the involvement of 
QCR was reported.  More recently, a cytochrome 
c gene located at the gene cluster for chlorate 
respiration in I. dechloratans has been cloned and 
over-expressed in E. coli but demonstrated not to 
function as an electron donor to purified chlorate 
reductase (49).  It is interesting to speculate what 
the functions of the additional c-type cytochromes 
are in T. selenatis when grown on selenate.  The 
mechanism by which selenite is reduced remains 
unknown.  What is clear is that the reduction of 
selenite results in the formation of selenium 
nanospheres that are found in the surrounding 
medium.  For the elemental selenium to form 
extra-cellular particles it is considered likely that 
selenite is reduced either in the periplasm or on 
the outer cell surface, and as a consequence the 
other cytochromes identified might form an 
electron conduit to selenite reductase. 
The involvement of QCR in the respiratory 
electron transfer chain of T. selenatis was 
suggested from the genome analysis (Genbank 
accession EU732596.1) and confirmed by 
complete inhibition of nitrite respiration by 
myxothiazol.  T. selenatis expresses a cd1 nitrite 
reductase (also identified in the T. selenatis 
genome (Genbank accession AY078264.1) which 
commonly receives electrons from QCR via 
soluble intermediates (cytochromes/azurins).  
Selenate respiration was only partially inhibited 
(70% reduction in μmax) by the same concentration 
of myxothiazol or antimycin A and completely 
inhibited by HQNO.  QCR binds two quinol 
molecules at the periplasmic face of the 
membrane and moves two electrons to the 
cytoplasmic face of the membrane, where it 
reduces one quinone molecule.  This so called Q-
cycle translocates two positive charges per quinol 
oxidized.  Given that myxothiazol and antimycin 
A are specific inhibitors of QCR, a redox loop 
coupling a Q-cycle mechanism to selenate 
reduction would seem plausible.  HQNO is a less 
specific quinone analogue which inhibits both 
QCR and other membrane-bound QDHs (31,32).  
HQNO alone, or in combination with 
myxothiazol, resulted in the complete inhibition 
of growth of T. selenatis.  These data suggest that 
selenate reductase can accept electrons from more 
that one electron donor.  A branched pathway that 
involves both QCR and QDH is proposed (Figure 
7).  A QDH partner has not been identified, but 
analysis of the c-type cytochromes in membrane 
fractions from T. selenatis, grown on selenate, 
reveals that cytochromes of ~30 kDa and ~20 kDa 
are present, but attempts to purify these 
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components have so far proved unsuccessful (data 
not shown).  A napC/nirT homologue (50) has 
also been identified in the T. selenatis genome 
that could be a likely candidate.                  
The ability to utilise a QCR dependent 
bioenergetic pathway is facilitated by the high 
redox potential of the selenate/selenite couple (Em 
+475 mV).  This allows the selenate reductase to 
function by using a high potential cytochrome c as 
the electron donor.  The interesting feature of SER 
thus relates to the point of electron entry and the 
unusual b-heme in SerC.  The determination of 
the redox potential of the SerC heme has allowed 
us to add to our knowledge of the redox centres of 
the selenate reductase and is the first periplasmic 
reductase of the Type II molybdo-enzymes to 
have the potential of its b-heme determined.  
Figure S2 (supplemental) shows the known 
midpoint potentials of all redox centres within 
SER, from the redox potential of the substrate to 
the potential of b-heme subunit.  The value of Em 
= +234 ±10 mV for the SerC b-heme is very 
similar to that determined for EbdC (+254 mV).  
EBDH functions by withdrawing electrons from 
ethylbenzene, where the b-heme functions as an 
electron attractant.  Conceptually, to convert from 
a dehydrogenase function to a reductase function, 
one might assume that the potential of the 
corresponding b-heme in the type II molybdo-
reductases might be retuned to function at a much 
lower redox-potential, thus facilitating electron 
donation.  This appears not to be the case for 
selenate reductase.  It is of interest to compare 
SerC/EbdC cytochromes to the membrane-bound 
cytochrome associated with the respiratory nitrate 
reductase (NarI).  NarI contains two b-hemes, but 
both have much lower redox potential (+120 and 
+20 mV).  Modelling the three dimensional 
structure of SerC, using the X-ray co-ordinates of 
EbdC from A. aromaticum, predicts that the b-
heme in SerC is also co-ordinated by methionine 
(M138) and lysine (K228) ligands (Figure 8).  In 
NarI, both hemes have Fe with bis-histidinyl co-
ordination and this could contribute to the 
differences in redox potential.  The sulfur of 
methionine residues is a good electron acceptor, 
and could contribute to stabilizing the reduced 
state of the heme, therefore significantly raising 
the midpoint potential.   
Evidently the combination of a high potential 
b-heme in SerC and the unusual high potential 
redox couple of the substrate (selenate/selenite) 
has provided a system that can readily accept 
electrons from cyt-c and QCR redox partners.  By 
using these redox partners, selenate reduction can 
be linked to a Q-cycle mechanism.  Since selenate 
reductase functions on the positive side of the 
cytoplasmic membrane, the reduction of selenate 
to selenite will consume two pumped protons.  If 
SER was to receive electrons only from a 
membrane-bound quinol dehydrogenase (QDH), 
then only two protons would be released to the 
periplasm, resulting in no net gain of proton 
electro-chemical gradient (0q+/2e-).  Because the 
reduction of selenite to selenium does not support 
growth, selenate reduction via a QDH could only 
be energy conserving if electron input into the Q-
pool was proton-motive (i.e. via an NADH 
dehydrogenase, a formate dydrogenase, or 
hydrogenase).  By using the Q-cycle mechanism a 
net gain of 2q+/2e- of proton electrochemical 
gradient can be maintained irrespective of the 
electron donor.     
Finally, the Q-cycle coupling mechanism 
presented for selenate reduction in T. selenatis, 
whilst a novel mechanism for electron transport to 
molybdoezymes in bacteria, might also be utilised 
in the Archaea (51).  Sequence analysis has 
suggested that the clade of TAT-translocated type 
II molybdoenzymes, of which SER is a member, 
also contains a number of unusual respiratory 
nitrate reductases (pNAR).  These reductases all 
possess a TAT leader peptide and are translocated 
to the positive side of the membrane.  The pNAR 
enzymes are distributed amongst the Archaea and 
examples have been identified in the 
hythermophiles and halophiles.  Interestingly, 
those from halophiles (Haloferax mediterranei 
and Haloarcula marismortui), lack a NarI-like 
component so the mechanism of electron transport 
is not obvious.  However, genetic analysis reveals 
the presence of a sequence that encodes a protein 
(NarC) similar to the di-heme subunits of QCR.  
Adjacent to the narC gene is a gene that encodes 
NarB which is predicted to encode a Rieske iron-
sulfur protein.  The combination of NarB and 
NarC in H. mediterranei has led to the suggestion 
that nitrate respiration in some organisms might 
be driven by a Q-cycle mechanism (51).  By 
coupling a Q-cycle mechanism to nitrate 
reduction would provide a pNAR system that is 
bioenergetically equivalent to the well 
characterised NAR (or nNAR) systems in 
bacteria.   
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FIGURE LEGENDS 
 
Figure 1.  Subunit organisation and redox cofactors of periplasmic type II molybdoenzymes.  Direction 
of electron transfer is indicated by the arrows.  Reductases include selenate and chlorate reductase.  
Dehydrogenases include dimethylsulphide and ethylbenzene dehydrogenases. 
 
Figure 2.  Cytochrome c profile from T. selenatis.  A; SDS-PAGE gels stained for c-type cytochromes, 
showing periplasmic cytochromes (cytc-Ts1-7) expressed during selenate and/or nitrate respiration. Lane 1 – 
Invitrogen SeeBlue Plus2 Prestained Standard. Lane 2 – periplasmic fraction from selenate grown cells 
(heme stained). Lane 3 – periplasmic fraction from nitrate grown cells (heme stained).  7 µg of protein was 
loaded in each lane.  Lane 4; purified cytc-Ts4 (~24 kDa) stained with Invitrogen SeeBlue Plus2.  Lane 5 
purified cytc-Ts4 (~24 kDa) stained with heme stain.  Lane 6 purified cytc-Ts7 (~6 kDa) stained with 
Invitrogen SeeBlue Plus2.  Lane 7 purified cytc-Ts7 (~6 kDa) stained with heme stain. B; Spectra of 25 μM 
cytc-Ts4 (~24 kDa protein) as purified (solid line), reduced with sodium dithionite (dotted line) and oxidized 
with potassium ferricyanide (dashed line).  C; Spectra of 25 μM cytc-Ts7 (~6 kDa protetin) as purified (solid 
line), reduced with sodium dithionite (dotted line) and oxidized with potassium ferricyanide (dashed line).   
 
Figure 3.  Spectroscopic assay of electron donation from cytc-Ts4 to SerABC.  Cytc-Ts4 (5 μM) reduced 
with dithionite (dashed line) was mixed with 1 μM SerABC and 20 mM selenate and re-oxidation was 
monitored by wavelength scanning UV-visible spectroscopy (solid line). 
 
Figure 4.  Optical redox titration of cytc-Ts4.  A; α and β region of cytc-Ts4 spectrum during titrations. 
Black arrow indicates increasing redox potential.  B; Fraction of cytochrome reduced as calculated with 
reference to absorbance at 551 nm, as a function of redox potential.  Nernst curves for n=1 electrons (dashed 
line) and n=2 electrons (solid line) are also shown.  
 
Figure 5.  Optical redox titration of SerC.  A; shows the α and β region of b-heme spectrum during 
titrations.  Black arrow indicates increasing redox potential. Samples were prepared in 30 mM Tris-HCl 
pH7.5. B; Fraction of cytochrome b reduced as calculated with reference to absorbance at 558 nm, as a 
function of redox potential.  Nernst curve for n=1 electron.   
 
Figure 6.  Inhibition of respiration by myxothiazol, antimycin A and HQNO.  A; Optical density of T. 
selenatis cultures grown with 10 mM selenate as electron acceptor in the absence and presence of inhibitors.  
No inhibitor (); 10 μM myxothiazol (¡); 20 μM HQNO (z) and both 10 μM myxothiazol and 20μM 
HQNO (T).  Positive control: T. selenatis grown with 5 mM nitrite as electron acceptor in the presence of 
10 μM myxothiazol ({).  B; Optical density of T. selenatis cultures grown with 10 mM selenate as electron 
acceptor in the absence and presence of antimycin A.  No inhibitor (); 10 μM antimycin A (¡); 20 μM 
antimycin A (z).  C; Specific growth rate (μmax) of T. selenatis cultures grown on increasing [selenate] in the 
absence () and presence of myxothiazol (z) (10 μM).  In all cases error bars represent standard deviation 
of n=10 cultures. 
 
Figure 7.  Schematic diagram showing the electron transport chain of T. selenatis during anaerobic 
growth on selenate.  
 
Figure 8. b-heme co-ordination in SerC.  A: Predicted structure of SerC modelled upon the crystal 
structure of EBDH γ-subunit.  Superposition shown; SerC is in green and the EbdC is in cyan.  B: Detail of 
heme pocket showing ligands.  Homology modelling was performed using the homology tools in the 
software package MOE™.  The sequence of T. selenatis SerC was aligned and modelled against the structure 
of EBDH γ-subunit from A. aromaticum (PDB – 2IVF C).  The sequence was modelled from residues 27 to 
239.  The modelling was performed using the protein template alone, and additionally using the environment 
of the template structure with the heme ligand.  An ensemble of 30 intermediate models was created and the 
best intermediate model as minimized using the CHARM22 force field to an RMS gradient of 0.01.  The 
quality of the models was assessed by PROCHECK (52, 53).  Analysis of the model structure and generation 
of molecular images were carried out using PyMol (54). 
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Lowe et al.   Figure 2 
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Lowe et al.   Figure 3 
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Lowe et al.   Figure 4 
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 Lowe et al.   Figure 5 
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Lowe et al.   Figure 6 
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Lowe et al.   Figure 7 
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 Lowe et al.   Figure 8 
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Figure S1.  Sequence alignments of cytochromes c4 and sequence for the 24 kDa cytochrome c from T. 
selenatis.  Bacterial strains from which sequence data is taken are abbreviated as follows (Genbank 
accession numbers for protein sequences are in parenthesis); Ts – Thauera selenatis (GU570563), Da – 
Dechlomonas aromatica RCB (AAZ46318.1), Mg – Magnetospirillum gryphiswaldense MSR1 
(CAM74905.1). Mm – Magnetospirillum magneticum (BAE51887.1), Ps – Pseudomonas stutzeri 
(AAA20247.1|), Af – Acidithiobacillus ferrooxidans (CAA07032.1), Pp – Pseudomonas putida GB-1 
(ABY96057.1), Av – Azotobacter vinelandii (AAA87314.1), Sb – Shewanella baltica OS195 
(ABN59587.1), So – Shewanella oneidensis MR-1 (AE015898_8), Vp – Vibrio parahemeolyticus AQ3810 
(EDM58639.1), Pe – Pseudomonas entomophila L48 (CAK13073.1) and Tr – Thiocapsa roseopersicina 
(P86052.1). Cytochrome c binding motifs (CXXCH) and conserved axial methionine residues (M) are 
underlined.  All conserved residues are marked with an asterisk.  
 
Figure S2.  Electron transfer during selenate respiration.  The known Em values of each of the 
components involved in electron transfer to selenate through the selenate reductase system.  Q-pool indicates 
ubiquinol (Eo'~+65 mV) and menaquinol (Eo'~-55 mV).  Arrows indicate direction of electron transfer.  
Lowe et al.   Figure S1 
 
 
 
Ts ------------GPPAPKK-EGIEGQGYVWNAQEGEKIEALQKKGDVTRGEEAYEVCGACHLPSG 
Da ------------GPPAPHK-EGIESKDYKWNAEGGEKMEALHKKGNVKNGEEVYEICGACHLPSG 
Mg -------------KDKPAQGKLLGDKDYQWNANGGEKDEAEHLKPDLKNGRDVYEVCAACHLPEG 
Mm ----------AGGG-TPQKGKSLGEEGYQWHAGGGEEDEALHLKPDLANGKEVYEVCSACHQMEG 
Ps -------------------------------AGDAEAGQGKV------------AVCGACHGVDG 
Af ------------------------------AVGSADAPAPYRVS----------SDCMVCHGMTG 
Pp ---------------------------AQPIKGDAAAGQAKT------------AVCGACHNPDG 
Av -------------------------------AGDAAAGQGKA------------AVCGACHGPDG 
Sb -------------------------------EGNAEAGKTKI------------IVCSACHGMDG 
So -------------------------------EGNAEAGKTKI------------IVCSACHGMDG 
Tr ---------------------TDGHQAAAPQVGDPQAGEAKAN-----------GVCLACHGPQG 
                                                         *  **   * 
 
Ts AGRPDGTFPQLAGQHTTVLIKQMADIRAGL---------RDNPTMYPFAA--TLVDPQELADVSA 
Da AGRADGTFPQLAGQHSTVLIKQMADIRSGE---------RDNPTMYPFAS--TLTDPQELADAAA 
Mg WGQTDGTFPQLAGQHPKVIIKQLADIRALN---------RDNPTMYPFALPDQIGGPQAIADVAA 
Mn WGLTDGTFPQLAGQHPKVVIKQLADIRALN---------RDNPTMYPFALPSQIGGPQAIADVAA 
Ps -NSPAPNFPKLAGQGERYLLKQLQDIKAGSTPGAPEGVGRKVLEMTGMLDP---LSDQDLEDIAA 
Af RDTLYPIVPRLAGQHKSYMEAQLKAYKDHSRADQ-----NGEIYMWPVAQA---LDSAKITALAD 
Pp -NSLAPNFPKLAGQGQRYLEKQLHDIKSGK---------RTVLEMTGMLTA---FSDQDLADIAA 
Av -NSAAPNFPKLAGQGERYLLKQMQDIKAGTKPGAPEGSGRKVLEMTGMLDN---FSDQDLADLAA 
Sb -NSMIDMYPKLAGQHATYLQKQLHDFRSAAQTGGKDG--RMDPIMSGMAMP---LSDQDILDITA 
So -NSMIDMYPKLAGQHATYLQKQIHDFRSAAQSGGKDG--RMDPIMSGMAMP---LSDQDILDISA 
Tr -NSLVPIWPKLAGQHPEYIVKQLMDFKQRR----------ANEQMTPMAMP---LTDQEVLDLAA 
         * ****       *                      *                     
 
Ts YIESLCIPTDHGKYEGADA--ALQVAKGKELYE--KQCKECHGDTG-AGDKAKFYPVIAGQHYKY 
Da YINSLCIPLEHGKYEGADA--AMQIAKGKELYE--KECLECHGKTG-EGNKEKFYPVIAGQHYKY 
Mg YIQ----KLKMNPEPGVGD--GKDLEHGKKLYK--DNCVRCHGEHG-EGNNDKYYPRLEGQHYNY 
Mn YMAV---KLKMNPEPGVGD--GKDLAHGKKLYE--ENCTRCHGADG-AGDNDKFYPRIQGQHYEY 
Ps YFSSQKGSVGYADPALAKQ--GEKLFRGGKLDQGMPACTGCHAPNG-VGNDLAGFPKLGGQHAAY 
Af YFNAQKPPMQSSGIKHAGAKEGKAIFNQGVTNEQIPACMECHGSDG-QGAG--PFPRLAGQRYGY 
Pp YFSSQKGSVGAADPKLVER--GRSLFNGGDLEKGMPACTGCHSPNG-AGIALAGFPHLGGQHSQY 
Av YFTSQKPTVGAADPQLVEA--GETLYRGGKLADGMPACTGCHSPNG-EGNTPAAYPRLSGQHAQY 
Sb YFSSQ-AIQVAEAKDVPEL--GAKLYKGGDVSRGITACMACHGPDG-KGAELAGFPTLAGQHANY 
So YFSTQ-KIQVAEVKDVPEL--GAKLYKGGDVSRGITACMACHGPDG-KGAESAGFPALAGQHANY 
Tr YYATQPKTPGAADPELASK--GESLYRWGNPETGVPACSGCHGPAGGAGQSLAKFPRLSAQHADY 
 *                                    *  **   *  *      *    *   * 
 
Ts LLRQMTEIR--DGHRRNANP--DMVKVIKPYTDDQLVAISAYQASLKMPGSMC----GDKK---- 
Da LLRQMTEIR--DGKRRNANP--DMVKIIKKYDNQQLIAISAYQSSMVMPGAMCKPKAGKKK---- 
Mg LIRQYQWIK--EGKRRNANP--DMVQQIKTFTDRDTKAVLDYVSRIKPPANLIGTKGWQNPDFQ- 
Mn LLRQYQWIK--EGKRRNANP--DMMKQIQSFTDRDTKAVLDYTSRLKPPANLVAPKGWKNPDFQ- 
Ps TAKQLTDFR--EGNRTNDGDTMIMRGVAAKLSNKDIEALSSYIQGLH------------------ 
Af IIQQLTYFH--NGTRVN----TLMNQIAKNITVAQMKDVAAYLLSS------------------- 
Pp VTKQLTDFR--EGNRTNDGDAMTMRTIAGKLSNHDIEALASYIQGLH------------------ 
Av VAKQLTDFR--EGARTNDGDNMIMRSIAAKLSNKDIAAISSYIQGLH------------------ 
Sb IKIQLTKFR--EAGRHNDLN-GMMQDVAKKLSDSDIDALSKYLSSLK------------------ 
So IKLQLTKFR--DAGRHNDLN-GMMQDVAKKLNDSDIDALSKYLASLK------------------ 
Tr TKQTLEHFR--GALRANDPNG-MMRGAAARLSDQEIAAVSQYLQGLSQ----------------- 
               * *      *                 * 
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